The 20 Best Cutaneous T-Cell Lymphoma (CTCL) Doctors Near Me in Michigan, US

Dr. Tejasvi received his medical degree from Karnataka Institute of Medical Sciences, India. He completed residency-training program and worked as senior resident in Dermatology and Venereology, from All India Institute of Medical Sciences, New Delhi, India. He completed post-doctoral training in genetics of psoriasis under the direction of Drs. R.P.Nair and James T. Elder at the University of Michigan, Department of Dermatology in Ann Arbor.Dr. Tejasvi's primary research interest is translational genetics, epigenetics in psoriasis and pharmacogenetics that involves application of genetic information to predict response to therapies. Dr. Tejasvi is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.

The T-cell lymphomas are a heterogeneous and poorly understood group of non-Hodgkin’s lymphomas. The most common T-cell lymphoma in the United States includes a heterogeneous mix of lymphomas that lack distinguishing characteristics and, until recently, remained clinically and molecularly “unspecified”. Improved understanding of T-cell lymphoma pathogenesis and the development of novel therapeutic strategies will be needed to address this challenge and improve outcomes for patients afflicted with these aggressive lymphomas. My group made the landmark discovery that the most common T-cell lymphoma in North America is comprised of two molecularly and clinically distinct subsets. This finding has significant implications for the classification and treatment of these lymphomas. We have also demonstrated that malignant T cells remain dependent upon antigen-presenting cells within the tumor microenvironment and are developing novel therapeutic strategies targeting these cells. Many fundamental questions, including the “cell of origin”, the role of antigen-, costimulatory-, and cytokine-receptor signaling, and the contribution of myeloid-derived antigen-presenting cells in disease pathogenesis remain obscure. My laboratory uses complementary mouse models and primary T-cell lymphoma specimens (in ex vivo and patient-derived xenograft studies) to address these fundamental and clinically relevant questions. We are poised to clinically translate our laboratory-based findings into novel therapeutic strategies that we hope will improve outcomes for patients afflicted with these aggressive lymphomas. I enjoy working with a multidisciplinary team of enthusiastic collaborators who share this common goal. Dr. Wilcox is rated as an Elite provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Wilcox is board certified in Internal Medicine, Hematology, and Medical Oncology.

Dr. Frank Wang, MD is a board-certified Dermatologist. He graduated from Stanford University and received his medical degree from Cornell University Medical College. Dr. Wang served his internship at the University of Pittsburgh Medical Center, and went on to complete a Fellowship and his Dermatology Residency here at the University of Michigan. In 2010, Dr. Wang joined the faculty at the University of Michigan Department of Dermatology. His interests and expertise include general clinical dermatology, and clinical and basic science research in the area of skin aging. Dr. Wang is rated as an Advanced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 58 other conditions, according to our data. His clinical expertise encompasses Psoriasis, Actinic Keratosis, Pyoderma Gangrenosum, and Acute Febrile Neutrophilic Dermatosis. Dr. Wang is board certified in Dermatology.

After receiving my M.D. and Ph.D. at the University of Alabama at Birmingham, I came to the University of Michigan for residency training in Anatomic Pathology. During my residency and subsequent Dermatopathology fellowship, I became interested in mechanistic studies of cutaneous and soft-tissue malignancies. Upon completion of my fellowship in June 2012, I accepted a faculty position at UMHS with joint appointments in the Departments of Dermatology and Pathology, in which I continue to investigate molecular events in the pathogenesis of Merkel cell carcinoma and other cutaneous malignancies, while maintaining clinical effort in dermatopathology and molecular dermatopathology. Dr. Harms is rated as an Advanced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Tieche-Jadassohn Nevus, Melanoma, and Sebaceous Adenoma. Dr. Harms is board certified in Pathology-Anatomic and Dermatopathology.

Dr. Lauren Smith received her undergraduate degree at the University of Michigan Honors College with highest distinction in 1992. She spent four years working in a neurogenetics laboratory at the University of San Francisco with Dr. Nelson Freimer. For the next two years she worked as a manuscript editor for Dr. Donald Klein, a psychiatrist, at Columbia University. In 1998, she began medical school at the University of Michigan. She was awarded AOA in her junior year and was president of the UM AOA Chapter the following year. She completed her residency in anatomic/clinical pathology and fellowship in hematopathology from 2002-2007. In July, 2007 she began her faculty career as an Assistant Professor at the University of Michigan and was promoted to Associate Professor in 2013. She was appointed Fellowship Director in 2013. She was appointed the Director of the Ethics Path of Excellence in the University of Michigan Medical School in 2013. She became the permanent Director of the Hematopathology Section in 2016. In addition, she serves as a Hospital Ethicist at UMHS. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, T-Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, and Peripheral T-Cell Lymphoma.

Johann Gudjonsson, MD, PhD is the Arthur C. Curtis Professor of Molecular Skin Immunology and the Frances and Kenneth Eisenberg Emerging Scholar of the Taubman Medical Research Institute. A graduate of the University of Iceland Medical School, he completed his internship and dermatology residency training at the University of Michigan. Dr. Gudjonsson has served on the faculty of the University of Michigan Department of Dermatology since 2008. He provides general medical dermatology patient care at the University of Michigan Taubman Center and maintains clinical and research interests in inflammatory and autoimmune disorders involving the skin.Dr. Gudjonsson came to the U-M in 2003 as part of an innovative research residency training program. Building upon investigative dermatology training completed in Iceland, Dr. Gudjonsson has been performing basic immunological and genetic work on psoriasis at the U-M. Dr. Gudjonsson's primary research focus is basic immunological and genetic research on psoriasis, with projects directed at improving the diagnosis and treatment of psoriasis. He received the 2007 Young Investigator Award from the American Academy of Dermatology, was named the 2018 Rising Star Lecturer for the Society for Investigative Dermatology and was recipient of the American Skin Association Research Achievement Award in Psoriasis in 2021. Dr. Gudjonsson's research has been supported by research awards from the National Institutes of Health (NIH), the American Skin Association, Dermatology Foundation, Doris Duke Foundation, among others. Dr. Gudjonsson is rated as an Advanced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Benign Chronic Pemphigus, Psoriasis, Darier Disease, Cutaneous Lupus Erythematosus (CLE), and Vitrectomy. Dr. Gudjonsson is board certified in Dermatology.

Alexandra Hristov is a Hematologist and a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Hristov is rated as a Distinguished provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, T-Cell Lymphoma, and Sezary Syndrome. Dr. Hristov is board certified in Dermatopathology, Pathology-Anatomic/Pathology-Clinical, and Hematopathology.

Mark Kaminski is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Kaminski is rated as a Distinguished provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Follicular Lymphoma, Non-Hodgkin Lymphoma, Gastric Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Bone Marrow Aspiration.

Ben Friedman is a Dermatologist practicing medicine in West Bloomfield, Michigan. Dr. Friedman is rated as an Advanced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Mycosis Fungoides, Muir-Torre Syndrome, Giant Congenital Nevus, and Dermatomyositis.

Brent Boyce is a Dermatologist practicing medicine in Sebewaing, Michigan. Dr. Boyce is rated as an Advanced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Plaque Psoriasis, Seborrheic Keratosis, Neurocutaneous Melanosis, and Familial Atypical Multiple Mole Melanoma Syndrome.

Benjamin Workman is a Dermatologist practicing medicine in Bay City, Michigan. Dr. Workman is rated as an Advanced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Plaque Psoriasis, Psoriasis, Neurocutaneous Melanosis, and Seborrheic Keratosis.

Kevin Gaffney is a Dermatologist practicing medicine in Flint, Michigan. Dr. Gaffney is rated as an Advanced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 146 other conditions, according to our data. His clinical expertise encompasses Universal Acquired Melanosis, Liver Spots, Papular Urticaria, and Rosacea.

Dr. Lowe received her undergraduate degree from Occidental College, Los Angeles, California in 1981 and her M.D. degree from the University of Texas Medical School at Houston, Houston, Texas in 1985. She did a transitional internship at St. Joseph's Hospital, Houston, Texas from 1985-1986 and then was a Post-doctoral Fellow in the Department of Dermatology at the University of Texas Medical School at Houston. From 1987-1989, she completed her residency training in dermatology at the University of Texas Medical School at Houston, followed by a Dermatopathology Fellowship at the University of Colorado School of Medicine, Denver, Colorado, from 1990-1991. Dr. Lowe is board certified in both Dermatology and Dermatopathology.In 1990, Dr. Lowe served as an Instructor in the Department of Dermatology at the University of Texas Medical School at Houston, Houston, Texas. She moved to the Department of Dermatology at Henry Ford Hospital, Detroit, Michigan, where she was a Senior Staff Physician and Director of Dermatopathology from 1991-1996. In 1996 she joined the faculty of the Departments of Pathology and Dermatology at the University of Michigan Medical School, Ann Arbor, Michigan, as Assistant Professor, where she was promoted to Associate Professor in 1998, and to Professor in 2004. She served as the Director of Dermatopathology in the Department of Pathology from 1996-2012.While at the University of Michigan Medical School, Dr. Lowe has been actively involved in the dermatopathology service, teaching and academic pursuits. She has been recognized institutionally and nationally as an educator and clinician. In 2013, Dr. Lowe received the Walter Nickel Teaching Award given by the American Society of Dermatopathology and also received the Outstanding Clinician of the Year Award bestowed by the University of Michigan Medical School. In 2015, she was inducted into the University of Michigan League of Clinical Excellence. Dr. Lowe received the William B. Taylor Resident Teaching Award from the Department of Dermatology, University of Michigan in 1999 and 2005 for exemplary teaching. She has been recognized annually since 2003 in America's Top Doctors for Cancer by Castle Connolly Medical Ltd. She has served on national committees, including the American Board of Dermatology, Dermatopathology Test Committee and the American Board of Pathology, Dermatopathology Test Committee and has served on the editorial boards of both the Journal of the American Academy of Dermatology and Cancer. Dr. Lowe is the author or co-author of more than 130 publications in peer-reviewed journals. Dr. Lowe is rated as an Advanced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Sebaceous Adenoma, Syringocystadenoma Papilliferum, and Syringoma. Dr. Lowe is board certified in Dermatology and Dermatopathology.

John Runge is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Runge is rated as an Advanced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Sezary Syndrome, and Lymphomatoid Papulosis.

Jennifer Nash is a Dermatologist practicing medicine in Midland, Michigan. Dr. Nash is rated as an Advanced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Sunburn, Hidradenitis Suppurativa, and Psoriasis.

Gregory Messenger is a Dermatologist practicing medicine in Lansing, Michigan. Dr. Messenger is rated as an Advanced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 135 other conditions, according to our data. His clinical expertise encompasses Actinic Keratosis, Warts, Seborrheic Keratosis, and Basal Cell Skin Cancer.

Michael Raad is a primary care provider, practicing in Internal Medicine in Sterling Heights, Michigan. He has been practicing medicine for over 42 years. Dr. Raad is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, Osteotomy, and Endoscopy. Dr. Raad is board certified in American Osteopathic Board Of Internal Medicine. Dr. Raad is currently accepting new patients.

Julie Byrd is a Dermatologist practicing medicine in Rochester Hills, Michigan. She has been practicing medicine for over 26 years. Dr. Byrd is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Neurocutaneous Melanosis, Giant Congenital Melanocytic Nevus, Giant Congenital Nevus, and Familial Atypical Multiple Mole Melanoma Syndrome. Dr. Byrd is board certified in American Board Of Dermatology. Dr. Byrd is currently accepting new patients.

Erin Pettijohn is a Hematologist and a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. She has been practicing medicine for over 15 years. Dr. Pettijohn is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 47 other conditions, according to our data. Her clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, B-Cell Lymphoma, Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration. Dr. Pettijohn is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Pettijohn is currently accepting new patients.

David Byrd is a Dermatologist practicing medicine in Rochester Hills, Michigan. He has been practicing medicine for over 30 years. Dr. Byrd is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Actinic Keratosis, and Warts. Dr. Byrd is board certified in American Board Of Dermatology and American Board Of Dermatology. Dr. Byrd is currently accepting new patients.